Hence, we sought out to test if JAKs were involved in the activation of STAT3 in MCS of colon cancer cells and whether JAK-inhibition can affect induction of IRF9 and the panel of IRDS genes. The gene discussed is IRF9; the disease is malignant colon neoplasm.